ALDURAZYME 100 U/ml, concentrate for solution for infusion bottle, 5 ml, CIP 3400956491711
Active ingredients: Laronidase
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusionbottle, 5 ml, CIP 3400956491711intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALDURAZYME 100 U/ml, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 5 ml ( abrogée le 12/09/2024)
- Marketing authorisation holder
- SANOFI (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 3 Nov 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66328396CIP75649171CIP133400956491711Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LARONIDASEsolution | 100 U · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.